Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan;43(1):109-116.
doi: 10.1002/pd.6285. Epub 2022 Dec 15.

The inequity of targeted cystic fibrosis reproductive carrier screening tests in Australia

Bennett O V Shum  1   2 , Letitia M F Sng  3   4 , Rasa Ruseckaite  5 , Ilya Henner  1 , Natalie Twine  3   4 , Denis C Bauer  3   4   6 , Urs Wilgen  7 , Carel Pretorius  7 , Paulette Barahona  1 , Jacobus P J Ungerer  7   8 , Glenn Bennett  1
Affiliations

The inequity of targeted cystic fibrosis reproductive carrier screening tests in Australia

Bennett O V Shum et al. Prenat Diagn. 2023 Jan.

Abstract

Objective: European and Australian guidelines for cystic fibrosis (CF) reproductive carrier screening recommend testing a small number of high frequency CF causing variants, rather than comprehensive CFTR sequencing. The study objective was to determine variant detection rates of commercially available targeted reproductive carrier screening tests in Australia.

Methods: Next-generation DNA sequencing of the CFTR gene was performed on 2552 individuals from a whole population sample to identify CF causing variants. The variant detection rates of two commercially available Australian reproductive carrier screening tests, which target 50 or 175 CF causing variants, in this population were calculated. The ethnicity of individuals was determined using principal component analysis.

Results: Variant detection rates of the tests for 50 and 175 CF causing variants were 88.2% and 90.8%, respectively. No CF causing variants in individuals of East Asian ethnicity (n = 3) were detected by either test, while >86.6% (n = 69) of CF causing variants in Europeans would be identified by either test.

Conclusions: Reproductive carrier screening tests for a targeted set of high frequency CF variants are unable to detect approximately 10% of CF variants in a multiethnic Australian population, and individuals of East Asian ethnicity are disproportionally affected by this test limitation.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

  • Cystic fibrosis year in review 2023.
    Swetland DV, Savant AP. Swetland DV, et al. Pediatr Pulmonol. 2024 Dec;59(12):3106-3116. doi: 10.1002/ppul.27190. Epub 2024 Jul 26. Pediatr Pulmonol. 2024. PMID: 39056532 Free PMC article. Review.

References

REFERENCES

    1. Massie RJ, Curnow L, Glazner J, Armstrong DS, Francis I. Lessons learned from 20 years of newborn screening for cystic fibrosis. Med J Aust. 2012;196(1):67-70. https://doi.org/10.5694/mja11.10686
    1. Gregg AR, Aarabi M, Klugman S, et al. Screening for autosomal recessive and X-linked conditions during pregnancy and preconception: a practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2021;23(10):1793-1806. https://doi.org/10.1038/s41436-021-01203-z
    1. GAWGWsH Committee. Genetic carrier screening (C-Obs 63); 2019. Accessed December 4, 2022. https://ranzcog.edu.au/wp-content/uploads/2022/05/Genetic-carrier-screen...
    1. Delatycki MB, Burke J, Christie L, et al. Human Genetics Society of Australasia position statement: population-based carrier screening for cystic fibrosis. Twin Res Hum Genet. 2014;17(6):578-583. https://doi.org/10.1017/thg.2014.65
    1. Castellani C, Macek Jr. M, Cassiman JJ, et al. Benchmarks for cystic fibrosis carrier screening: a European consensus document. J Cyst Fibros. 2010;9(3):165-178. https://doi.org/10.1016/j.jcf.2010.02.005

Substances

Grants and funding